CYCLICAL MOOD CHANGES AS IN THE PREMENSTRUAL TENSION SYNDROME DURING SEQUENTIAL ESTROGEN‐PROGESTAGEN POSTMENOPAUSAL REPLACEMENT THERAPY

Acta Obstetricia et Gynecologica Scandinavica - Tập 64 Số 5 - Trang 393-397 - 1985
Stefan Hammarbäck1,2, Torbjörn Bäckström1,2, Juhani Hoist1,2, Bo von Schoultz1,2, Sven Lyrenäs1,2
1Department of Obstetrics and Gynecology, University of Umeå, Sweden
2Department of Physiology, University of Umeå, Sweden

Tóm tắt

Abstract. The etiology of the cyclical mood changes seen in the premenstrual syndrome is still unknown. A close relation to the luteal phase has been shown. One of the differences between the follicular and the luteal phase is the higher plasma progesterone concentration during the luteal phase. The present investigation has been conducted to study the effect of exogenously administered estrogen/gestagen sequential postmenopausal replacement therapy on mood and physical signs.Twenty‐two women requiring postmenopausal estrogen treatment were recruited and divided into two groups. Eleven women were given estradiol treatment only (Oestro‐gelR creme 3 mg percutaneously/day) for 21 days with a subsequent break of 7 days. The other 11 women were in addition given progestagen (Lynestrenol, OrgametrilR 5 mg/‐day) during the last 11 days of treatment. The women were asked to keep a daily record of their mood, using a visual analogue scale earlier tested in women with premenstrual syndrome. They also kept a record of physical signs and sexual feelings. The records were kept for between one and 6 months.The group with estrogen treatment only did not show any cyclical worsening in mood or physical signs during the treatment. The women who in the latter stage of the estrogen treatment cycle also received progestagen, showed significant cyclicity in both moods and physical signs, with a maximum symptom degree during the final days of gestagen treatment. The negative mood change started 1–3 days after the progestagen was added to the treatment. The results suggest that progestagens are involved in the provocation of cyclical symptom changes seen in the premenstrual syndrome.

Từ khóa


Tài liệu tham khảo

10.3109/01674828309081250

10.1111/j.1471-0528.1981.tb01028.x

10.1097/00006842-198312000-00004

10.1016/0022-4731(76)90115-1

10.1177/001316446602600204

10.1192/bjp.109.463.711

Cullberg J., 1972, Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo, Acta Psychiatr Scand, 236, 1

Dalton K., 1977, The Premenstrual Syndrome and Progesterone Therapy

10.1136/bmj.2.6202.1403

10.1210/jcem-2-3-157

Hoist J., Percutaneous estrogen replacement therapy effects on circulating estrogens, gonadotropins and prolactin, Acta Obstet Gynec Scand

10.1001/jama.1938.02790210001001

10.1192/bjp.113.496.265

Kohorn El, 1978, Endometrial Cancer, 179

10.1111/j.1471-0528.1981.tb00965.x

10.1111/j.1365-2125.1978.tb01676.x

10.1016/0002-9378(69)90499-2

10.1016/0002-9378(50)90475-3

10.1111/j.1365-2265.1981.tb00359.x

10.1136/bmj.280.6224.1161

10.1136/bmj.1.4818.1014

10.1097/00006842-198312000-00003

10.1210/jcem-44-4-771

Smith S L., 1975, Topics in Psychoendocrinology, 19

10.1016/0306-4530(77)90002-6

10.1111/j.1600-0447.1979.tb00267.x

Wolkowitz J., 1976, Introductory Statistics for the Behavioural Sciences, 59

Wonnacott T H., 1972, Introductory Statistics, 213

Thông tin
Thông tin xuất bản

Acta Obstetricia et Gynecologica Scandinavica

Tập 64 Số 5

393-397

Thông tin tác giả